tm
Seeing Is Believing
tm
Seeing Is Believing
YMAB is currently covered by 7 analysts with an average potential upside of $8.67 (41.71%) from yesterday's end of day stock price of $6.22. YmAbs Therapeutics activity chart has currently 10 price targets and 25 ratings on display.
Analysts average stock forecasts to be materialized ratio is 48.81% with an average time for these price targets to be met of 121.57 days.
Highest price target for YMAB is $17, Lowest price target is $3, average price target is $10.
Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 22-Aug-2023. First documented stock forecast 01-Apr-2019.
Currently, out of the existing stock ratings of YMAB - 6 which are a Hold (33.33%), 8 which are a Buy (44.44%), 4 which are a Sell (22.22%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
7
$0.78 (12.54%)
7
3 months 14 days ago
1/4 (25%)
$6.16 (54.46%)
190
Sell
5
$-1.22 (-19.61%)
7
3 months 22 days ago
3/3 (100%)
$-1.32 (-16.74%)
30
Buy
11
$5.74 (109.13%)
11
3 months 22 days ago
1/4 (25%)
$13.27 (79.52%)
403
Hold
6
$-0.22 (-3.54%)
5
6 months 21 days ago
2/3 (66.67%)
$6.09 (13.34%)
45
Hold
8 months 3 days ago
0/1 (0%)
$12.32 (83.92%)
What is YMAB (YmAbs Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on YMAB (YmAbs Therapeutics) with a proven track record?
Which analyst has the current lower performing score on YMAB (YmAbs Therapeutics) with a proven track record?
Which analyst has the most public recommendations on YMAB (YmAbs Therapeutics)?
Which analyst is the currently most bullish on YMAB (YmAbs Therapeutics)?
Which analyst is the currently most reserved on YMAB (YmAbs Therapeutics)?
